Brought to you by the Center for Professional Development with a special thank you to the content writers and presenters, Theresa A. Kuracina, MS, RD, CDE, LN, and Andrew Narva, MD, FACP, at the National Kidney Disease Education Program (NKDEP)
This module covers certain complications seen in CKD. The risk for anemia, hypoalbuminemia, hyperkalemia, metabolic acidosis, and mineral and bone disorders increase as the estimated Glomerular Filtration Rate (eGFR) decreases. We will follow a patient, Joseph, as his CKD complications impact his life and journey towards kidney failure. You will use the National Kidney Disease Education Program's Your Kidney Test Results as we describe these complications.
CPE Level: 2
Suggested Learning Need Codes: 5340, 5000, 3060, 5230, 5130
- Use laboratory parameters to assess anemia in chronic kidney disease (CKD).
- Associate increased risk for hyperkalemia with hyperglycemia and metabolic acidosis in CKD.
- Use and interpret laboratory parameters to assess hypoalbuminemia in CKD.
- Use and interpret laboratory parameters to assess metabolic acidosis in CKD.
- Use and interpret laboratory parameters to assess CKD bone disorders.
This e-learning self-study includes web links to Your Kidney Test Results and Chronic Kidney Disease (CKD) and Diet: Assessment, Management and Treatment from the National Kidney Disease Education Program (NKDEP) Web site and additional Online Learning opportunities.
The course includes PDF files of the speaker presentations and handouts as well as a downloadable CPE certificate.
The Certificate of Training program consists of five separate modules that build on each other. To receive the certificate associated with this training, all five modules and related tests must first be completed and a subsequent final post test exam in Module 5 must be passed with a minimum of an 80% in order to receive the Certificate of Training. The Certificate of Training can then be downloaded and printed from the site.
Revised modules now reflect the following recommendations for CKD patients:
- Sodium intake of < 2,300 mg rather than < 1,500 mg per day (IOM, 2013)
- Blood pressure target of < 140/90 mm Hg rather than < 130/80 mm Hg (JNC 8, 2014)
- Initial antihypertensive treatment with an ACEi or ARB (JNC 8, 2014).
Immediately following purchase, you will receive an access email for the module. This email contains a link which will remain active for 30 days once the link has been activated by the user.
This product is approved for individual use only. Only the registered participant is eligible for continuing professional education units.
Please note: Upon completion of your order, a link to access your purchase will be sent to the email address you have on file with the Academy. Please be sure your email address is accurate before submitting your order. If you have difficulty with your purchase, please contact email@example.com. Thank you.